Andrew Huberman· PhD
what we don't have for glaucoma we can come back to like kind of what's The Cutting Edge or the future uh in these eye diseases what we don't have are treatments that really Target the optic nerve degenerative process
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
what we don't have for glaucoma we can come back to like kind of what's The Cutting Edge or the future uh in these eye diseases what we don't have are treatments that really Target the optic nerve degenerative process
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
There are currently “no regenerative therapeutics for glaucoma and no therapeutics at all for NAION,”